Ficlatuzumab |
| Catalog No.GC69110 |
Ficlatuzumab est un anticorps monoclonal ciblant le facteur de croissance des hépatocytes humains (HGF). Ficlatuzumab peut bloquer l'activation de la voie de signalisation HGF/c-Met, inhiber la prolifération, la migration et l'invasion des cellules cancéreuses médiées par le récepteur c-Met.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1174900-84-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Ficlatuzumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Ficlatuzumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *